Sartorius Stedim Biotech (XPAR:DIM) Construction In Progress : €598 Mil (As of Dec. 2023)

View and export this data going back to 1994. Start your Free Trial

What is Sartorius Stedim Biotech Construction In Progress?

Sartorius Stedim Biotech's quarterly construction in progress stayed the same from Jun. 2023 (€0 Mil) to Sep. 2023 (€0 Mil) but then increased from Sep. 2023 (€0 Mil) to Dec. 2023 (€598 Mil).

Sartorius Stedim Biotech's annual construction in progress increased from Dec. 2021 (€288 Mil) to Dec. 2022 (€484 Mil) and increased from Dec. 2022 (€484 Mil) to Dec. 2023 (€598 Mil).

Sartorius Stedim Biotech Construction In Progress Historical Data

The historical data trend for Sartorius Stedim Biotech's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius Stedim Biotech Construction In Progress Chart

Sartorius Stedim Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Construction In Progress

Get a 7-Day Free Trial

80.04

125.67

288.20

483.95

597.50

Sartorius Stedim Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Construction In Progress	Get a 7-Day Free Trial															483.95	-	-	-	597.50

Sartorius Stedim Biotech Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Sartorius Stedim Biotech (XPAR:DIM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius Stedim Biotech SA (XPAR:DIM) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

SRTOY:USA SDMHF:USA DIM:Mexico DIMp:UK 0RG8:UK 56S1:Germany

Address

Otto-Brenner-Strasse 20, Goettingen, DEU, 37079

Website

https://www.sartorius.com

Sartorius Stedim Biotech, or SSB, is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs, and has a focus on single-use technology, or SUT. It is a subsidiary of Sartorius AG, which has a 74% ownership and 85% voting control. The business is geographically diverse.